chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site streaking, Injection site swelling, Pyrexia
Clinical narrative: Information has been received from a health professional concerning a patient (19 out of 40) who was vaccinated with Pneumovax 23 (lot number 651406/0620F).  It is unknown if the patient was vaccinated with the influenza virus vaccine (unspecified) on the same day.  Subsequently the patient experienced fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  Subsequently, the patient recovered from fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory.  The lot complies with the standards of the agency and was released.  Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site streaking, Injection site swelling, Pyrexia
Clinical narrative: Information has been received from a health professional concerning a patient (20 out of 40) who was vaccinated with Pneumovax 23 (lot number 651406/0620F). It is unknown if the patient was vaccinated with the influenza virus vaccine (unspecified) on the same day. Subsequently the patient experienced fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injected arm. Subsequently, the patient recovered from fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm. The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory. The lot complies with the standards of the agency and was released. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site streaking, Injection site swelling, Pyrexia
Clinical narrative: Information has been received from a health professional concerning a patient (21 out of 40) who was vaccinated with Pneumovax 23 (lot number 651406/0620F). It is unknown if the patient was vaccinated with the influenza virus vaccine (unspecified) on the same day. Subsequently the patient experienced fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm. Subsequently, the patient recovered from fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm. The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory. The lot complies with the standards of the agency and was released. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site streaking, Injection site swelling, Pyrexia
Clinical narrative: Information has been received from a health professional concerning a patient (22 out of 40) who was vaccinated with Pneumovax 23 (lot number 651406/0620F). It is unknown if the patient was vaccinated with the influenza virus vaccine (unspecified) on the same day. Subsequently the patient experienced fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm. Subsequently, the patient recovered from fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm. The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory. The lot complies with the standards of the agency and was released. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site streaking, Injection site swelling, Pyrexia
Clinical narrative: Information has been received from a health professional concerning a patient (23 out of 40) who was vaccinated with Pneumovax 23 (lot number 651406/0620F).  It is unknown if the patient was vaccinated with the influenza virus vaccine (unspecified) on the same day.  Subsequently the patient experienced fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  Subsequently, the patient recovered from fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory.  The lot complies with the standards of the agency and was released.  Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site streaking, Injection site swelling, Pyrexia
Clinical narrative: Information has been received from a health professional concerning a patient (24 out of 40) who was vaccinated with Pneumovax 23 (lot number 651406/0620F).  It is unknown if the patient was vaccinated with the influenza virus vaccine (unspecified) on the same day.  Subsequently the patient experienced fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  Subsequently, the patient recovered from fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory.  The lot complies with the standards of the agency and was released.  Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site streaking, Injection site swelling, Pyrexia
Clinical narrative: Information has been received from a health professional concerning a patient (25 out of 40) who was vaccinated with Pneumovax 23 (lot number 651406/0620F).  It is unknown if the patient was vaccinated with the influenza virus vaccine (unspecified) on the same day.  Subsequently the patient experienced fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  Subsequently, the patient recovered from fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory.  The lot complies with the standards of the agency and was released.  Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site streaking, Injection site swelling, Pyrexia
Clinical narrative: Information has been received from a health professional concerning a patient (26 out of 40) who was vaccinated with Pneumovax 23 (lot number 651406/0620F). It is unknown if the patient was vaccinated with the influenza virus vaccine (unspecified) on the same day. Subsequently the patient experienced fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm. Subsequently, the patient recovered from fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm. The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory. The lot complies with the standards of and was released. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site streaking, Injection site swelling, Pyrexia
Clinical narrative: Information has been received from a health professional concerning a patient (27 out of 40) who was vaccinated with Pneumovax 23 (lot number 651406/0620F).  It is unknown if the patient was vaccinated with the influenza virus vaccine (unspecified) on the same day.  Subsequently the patient experienced fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  Subsequently, the patient recovered from fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory.  The lot complies with the standards of the agency and was released.  Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site streaking, Injection site swelling, Pyrexia
Clinical narrative: Information has been received from a health professional concerning a patient (28 out of 40) who was vaccinated with Pneumovax 23 (lot number 651406/0620F). It is unknown if the patient was vaccinated with the influenza virus vaccine (unspecified) on the same day. Subsequently the patient experienced fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm. Subsequently, the patient recovered from fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm. The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory. The lot complies with the standards of the agency and was released. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site streaking, Injection site swelling, Pyrexia
Clinical narrative: Information has been received from a health professional concerning a patient (29 out of 40) who was vaccinated with Pneumovax 23 (lot number 651406/0620F).  It is unknown if the patient was vaccinated with the influenza virus vaccine (unspecified) on the same day.  Subsequently the patient experienced fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  Subsequently, the patient recovered from fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory.  The lot complies with the standards of the agency and was released.  Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site streaking, Injection site swelling, Pyrexia
Clinical narrative: Information has been received from a health professional concerning a patient (30 out of 40) who was vaccinated with Pneumovax 23 (lot number 651406/0620F).  It is unknown if the patient was vaccinated with the influenza virus vaccine (unspecified) on the same day.  Subsequently the patient experienced fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  Subsequently, the patient recovered from fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory.  The lot complies with the standards of the agency and was released.  Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Injection site erythema, Injection site streaking, Injection site swelling, Pyrexia
Clinical narrative: Information has been received from a health professional concerning a patient (31 out of 40) who was vaccinated with Pneumovax 23 (lot number 651406/0620F).  It is unknown if the patient was vaccinated with the influenza virus vaccine (unspecified) on the same day.  Subsequently the patient experienced fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  Subsequently, the patient recovered from fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory.  The lot complies with the standards of the agency and was released.  Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site streaking, Injection site swelling, Pyrexia
Clinical narrative: Information has been received from a health professional concerning a patient (32 out of 40) who was vaccinated with Pneumovax 23 (lot number 651406/0620F).  It is unknown if the patient was vaccinated with the influenza virus vaccine (unspecified) on the same day.  Subsequently the patient experienced fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  Subsequently, the patient recovered from fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory.  The lot complies with the standards of the agency and was released.  Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site streaking, Injection site swelling, Pyrexia
Clinical narrative: Information has been received from a health professional concerning a patient (33 out of 40) who was vaccinated with Pneumovax 23 (lot number 651406/0620F).  It is unknown if the patient was vaccinated with the influenza virus vaccine (unspecified) on the same day.  Subsequently the patient experienced fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  Subsequently, the patient recovered from fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory.  The lot complies with the standards of the agency and was released.  Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site streaking, Injection site swelling, Pyrexia
Clinical narrative: Information has been received from a health professional concerning a patient (34 out of 40) who was vaccinated with Pneumovax 23 (lot number 651406/0620F).  It is unknown if the patient was vaccinated with the influenza virus vaccine (unspecified) on the same day.  Subsequently the patient experienced fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  Subsequently, the patient recovered from fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory.  The lot complies with the standards of the agency and was released.  Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site streaking, Injection site swelling, Pyrexia
Clinical narrative: Information has been received from a health professional concerning a patient (35 out of 40) who was vaccinated with Pneumovax 23 (lot number 651406/0620F).  It is unknown if the patient was vaccinated with the influenza virus vaccine (unspecified) on the same day.  Subsequently the patient experienced fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  Subsequently, the patient recovered from fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory.  The lot complies with the standards of the agency and was released.  Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site streaking, Injection site swelling, Pyrexia
Clinical narrative: Information has been received from a health professional concerning a patient (36 out of 40) who was vaccinated with Pneumovax 23 (lot number 651406/0620F).  It is unknown if the patient was vaccinated with the influenza virus vaccine (unspecified) on the same day.  Subsequently the patient experienced fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  Subsequently, the patient recovered from fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory.  The lot complies with the standards of the agency and was released.  Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site streaking, Injection site swelling, Pyrexia
Clinical narrative: Information has been received from a health professional concerning a patient (37 out of 40) who was vaccinated with Pneumovax 23 (lot number 651406/0620F).  It is unknown if the patient was vaccinated with the influenza virus vaccine (unspecified) on the same day.  Subsequently the patient experienced fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  Subsequently, the patient recovered from fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory.  The lot complies with the standards of the agency and was released.  Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site streaking, Injection site swelling, Pyrexia
Clinical narrative: Information has been received from a health professional concerning a patient (38 out of 40) who was vaccinated with Pneumovax 23 (lot number 651406/0620F).  It is unknown if the patient was vaccinated with the influenza virus vaccine (unspecified) on the same day.  Subsequently the patient experienced fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  Subsequently, the patient recovered from fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory.  The lot complies with the standards of the agency and was released.  Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site streaking, Injection site swelling, Pyrexia
Clinical narrative: Information has been received from a health professional concerning a patient (39 out of 40) who was vaccinated with Pneumovax 23 (lot number 651406/0620F).  It is unknown if the patient was vaccinated with the influenza virus vaccine (unspecified) on the same day.  Subsequently the patient experienced fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  Subsequently, the patient recovered from fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory.  The lot complies with the standards of the agency and was released.  Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site streaking, Injection site swelling, Pyrexia
Clinical narrative: Information has been received from a health professional concerning a patient (40 out of 40) who was vaccinated with Pneumovax 23 (lot number 651406/0620F).  It is unknown if the patient was vaccinated with the influenza virus vaccine (unspecified) on the same day.  Subsequently the patient experienced fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  Subsequently, the patient recovered from fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory.  The lot complies with the standards of the agency and was released.  Additional information has been requested.
Age: 66.0
Sex: F
Vaccine: PPV
Symptoms: Breast pain, Erythema, Pain in extremity, Skin striae
Clinical narrative: Information has been received from a certified medical assistant concerning a 66 year old female (weight 132#, height 65") with no known drug allergies and a history of faecal incontinence who on 12-DEC-2006 was vaccinated intramuscularly in the left deltoid with a dose of Pneumovax 23 (lot 655290/0959F).  Concomitant therapy included levothyroxine Na, calcium citrate, vitamins (unspecified), ranitidine, ibuprofen, PREMARIN, "hydracil" and "laxative OTC".  On 12-DEC-2006 at 22:00, the patient developed marked redness, pain and streaking in the arm in which she was vaccinated with Pneumovax 23.  The pain radiated to her breast.  The patient had no fever.  The physician advised her to ice the area and prescribed KEFLEX 500 mg and BENADRYL.  On an unspecified date, the patient recovered from the events.  Additional information has been requested.
Age: 20.0
Sex: M
Vaccine: PPV
Symptoms: Body temperature, Body temperature increased, Dyspnoea, Influenza like illness, Injection site cellulitis
Clinical narrative: Information has been received from a certified medical assistant concerning a 20 year-old male student with severe asthma, allergies to penicillin and AVELOX and a history of frequent bronchitis who on 13-DEC-2006 in the evening was vaccinated intramuscularly with a 0.5 mL second dose of Pneumovax 23 (Lot # 655590/0885F).  Illness at the time of vaccination included upper respiratory infection and pharyngitis.  The next day ("about 24 hours after Pneumovax 23 was given"), the patient experienced flu-like symptoms with a high temperature (reported as 88 degrees), difficulty breathing and terrible injection site pain, swelling and redness.  The patient was also having some neck and muscle pain.  He was seen in the emergency room and was released.  On 15-DEC-2006, the patient was not able to move his arm and was seen by his doctor.  The injection site was erythematous and somewhat tender.  A diagnosis of cellulitis at injection site was made.  The patient was treated with ROCEPHIN IM 1g and LEVAQUIN 500 mg QD.  The patient was tested for meningitis and the cultures were negative.  Follow up was performed in 3 days and improvement was noted.  The patient recovered on 15-DEC-2006 after the appointment.  No product quality complaint was involved.  Additional information is not expected.
Age: 20.0
Sex: M
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Laboratory test normal, Mobility decreased
Clinical narrative: Information has been received from a certified medical assistant concerning a 20 year-old male student with severe asthma, allergies to penicillin and AVELOX and a history of frequent bronchitis who on 13-DEC-2006 in the evening was vaccinated intramuscularly with a 0.5 mL second dose of Pneumovax 23 (Lot # 655590/0885F).  Illness at the time of vaccination included upper respiratory infection and pharyngitis.  The next day ("about 24 hours after Pneumovax 23 was given"), the patient experienced flu-like symptoms with a high temperature (reported as 88 degrees), difficulty breathing and terrible injection site pain, swelling and redness.  The patient was also having some neck and muscle pain.  He was seen in the emergency room and was released.  On 15-DEC-2006, the patient was not able to move his arm and was seen by his doctor.  The injection site was erythematous and somewhat tender.  A diagnosis of cellulitis at injection site was made.  The patient was treated with ROCEPHIN IM 1g and LEVAQUIN 500 mg QD.  The patient was tested for meningitis and the cultures were negative.  Follow up was performed in 3 days and improvement was noted.  The patient recovered on 15-DEC-2006 after the appointment.  No product quality complaint was involved.  Additional information is not expected.
Age: 20.0
Sex: M
Vaccine: PPV
Symptoms: Myalgia, Neck pain
Clinical narrative: Information has been received from a certified medical assistant concerning a 20 year-old male student with severe asthma, allergies to penicillin and AVELOX and a history of frequent bronchitis who on 13-DEC-2006 in the evening was vaccinated intramuscularly with a 0.5 mL second dose of Pneumovax 23 (Lot # 655590/0885F).  Illness at the time of vaccination included upper respiratory infection and pharyngitis.  The next day ("about 24 hours after Pneumovax 23 was given"), the patient experienced flu-like symptoms with a high temperature (reported as 88 degrees), difficulty breathing and terrible injection site pain, swelling and redness.  The patient was also having some neck and muscle pain.  He was seen in the emergency room and was released.  On 15-DEC-2006, the patient was not able to move his arm and was seen by his doctor.  The injection site was erythematous and somewhat tender.  A diagnosis of cellulitis at injection site was made.  The patient was treated with ROCEPHIN IM 1g and LEVAQUIN 500 mg QD.  The patient was tested for meningitis and the cultures were negative.  Follow up was performed in 3 days and improvement was noted.  The patient recovered on 15-DEC-2006 after the appointment.  No product quality complaint was involved.  Additional information is not expected.
Age: 71.0
Sex: F
Vaccine: FLUX, PPV
Symptoms: Injection site irritation, Injection site swelling
Clinical narrative: Information has been received from a physician concerning a 71 year old female who on 14-DEC-2006 was vaccinated with a dose of Pneumovax 23 (Lot #651328/1046P).  Concomitant therapy given on the same day included a dose of influenza virus vaccine (unspecified).  On 14-DEC-2006, the patient developed irritation and swelling around the site of injection.  Unspecified medical attention was sought.  No laboratory studies were performed.  At the time of this report, the patient was recovering.  No product quality complaint was involved.  Additional information has been requested.
Age: 67.0
Sex: F
Vaccine: PPV
Symptoms: Body temperature increased, Oedema peripheral, Pitting oedema, Pyrexia
Clinical narrative: Information has been received from a physician concerning a 67 year old female with allergy to shellfish, bee stings and fire ants and a cold at the time of vaccination who on 14-DEC-2006 was vaccinated IM with a dose of Pneumovax 23 (lot #654977/0888F).  There was no concomitant medication.  On 14-DEC-2006 the patient developed 101 degree fever and swelling and pitting edema in the arm in which she was vaccinated.  Medical attention was sought and the patient was treated with BENADRYL and TYLENOL.  At the time of the report the patient had not recovered from the fever and the swelling had moved down to her forearm.  Additional information has been requested.
Age: 32.0
Sex: F
Vaccine: PPV
Symptoms: Asthma
Clinical narrative: Information has been received via a physician's assistant concerning a 32 year old female with asthma who on 16-DEC-2006 was vaccinated with a 0.5 mL dose of Pneumovax 23. On 17-DEC-2006 the patient developed cellulitis to her arm and presented to the emergency department. At the time of this report, the experience was still being treated and the outcome was unknown. Additional information has been requested.
Age: 29.0
Sex: M
Vaccine: PPV, TDAP
Symptoms: Body temperature increased, Chest pain, Dyspnoea, Injection site pain, Injection site swelling
Clinical narrative: Information has been received from a registered nurse concerning a 29 year old male with occupation of landscaping maintenance with type I diabetes mellitus and no known allergies or adverse drug reactions reported who on 09-NOV-2006, at 08:30, was vaccinated intramuscularly, into the left deltoid, with 0.5 mL first dose of Pneumovax 23 (Lot# 651356/0089F) concomitantly with a first dose of ADACEL (Lot C2492BA) intramuscularly, into the right deltoid. Other concomitant therapy included insulin. On approximately 09-NOV-2006, "a few hours after vaccination" the patient developed severe pain and moderate swelling at the left deltoid injection site with fever of 102, chest pains and dyspnea. The patient sought unspecified medical attention. A MEDROL dose pack was prescribed and the patient had gradually recovered over 5 days. Additional information is not expected.
Age: 29.0
Sex: M
Vaccine: PPV, TDAP
Symptoms: Pyrexia
Clinical narrative: Information has been received from a registered nurse concerning a 29 year old male with occupation of landscaping maintenance with type I diabetes mellitus and no known allergies or adverse drug reactions reported who on 09-NOV-2006, at 08:30, was vaccinated intramuscularly, into the left deltoid, with 0.5 mL first dose of Pneumovax 23 (Lot# 651356/0089F) concomitantly with a first dose of ADACEL (Lot C2492BA) intramuscularly, into the right deltoid. Other concomitant therapy included insulin. On approximately 09-NOV-2006, "a few hours after vaccination" the patient developed severe pain and moderate swelling at the left deltoid injection site with fever of 102, chest pains and dyspnea. The patient sought unspecified medical attention. A MEDROL dose pack was prescribed and the patient had gradually recovered over 5 days. Additional information is not expected.
Age: 78.0
Sex: M
Vaccine: PPV
Symptoms: Body temperature increased, Hyperhidrosis, Injection site erythema, Injection site swelling, Insomnia
Clinical narrative: Information has been received from a medical assistant concerning a 78 year old male with pertinent medical history and drug reactions/allergies reported as unspecified who on 18-DEC-2006 was vaccinated with Pneumovax 23 (lot # 651404/0352F) 0.5 ml.  On 18-DEC-2006, the patient experienced redness and swelling at the injection site, fever of 102-103 Fahrenheit, insomnia and sweating.  The patient sought medical attention.  No lab diagnostic tests were performed.  The patient was treated with BENADRYL.  The outcome of the events was unspecified.  Additional information has been requested.
Age: 78.0
Sex: M
Vaccine: PPV
Symptoms: Pyrexia
Clinical narrative: Information has been received from a medical assistant concerning a 78 year old male with pertinent medical history and drug reactions/allergies reported as unspecified who on 18-DEC-2006 was vaccinated with Pneumovax 23 (lot # 651404/0352F) 0.5 ml.  On 18-DEC-2006, the patient experienced redness and swelling at the injection site, fever of 102-103 Fahrenheit, insomnia and sweating.  The patient sought medical attention.  No lab diagnostic tests were performed.  The patient was treated with BENADRYL.  The outcome of the events was unspecified.  Additional information has been requested.
Age: 27.0
Sex: F
Vaccine: PPV
Symptoms: Body temperature increased, Injection site pain, Pain in extremity, Pyrexia, Tenderness
Clinical narrative: Information has been received from a registered nurse concerning a 27 year old female with no illness at the time of vaccination, and no drug reactions/allergies, and a history of postpartum cardiomyopathy, and fibromyalgia who on 13-DEC-2006 was vaccinated with a dose of Pneumovax 23 (lot # 655588/0883F) IM in the right deltoid at 1 PM.  Concomitant therapy included SYNTHROID, TOPROL XL TABLETS, DIOVAN, montelukast sodium (MSD), ZYRTEC, and NASACORT.  On 13-DEC-2006, the patient reported that the shot "hurt".  On 14-DEC-2006, the patient developed a fever of 104 degrees and also had a welt on her arm which was vaccinated.  The patient sought medical attention.  The patient was seen on 18-DEC-2006 in the evening, and the welt had decreased as well as her fever, however the patient's arm was still sore and tender.  The patient was treated with ROCEPHIN.  At the time of reporting, the patient was recovering.  Additional information was received from the registered nurse.  On an unspecified date, the patient recovered.  No additional information is expected.
Age: 27.0
Sex: F
Vaccine: PPV
Symptoms: Urticaria
Clinical narrative: Information has been received from a registered nurse concerning a 27 year old female with no illness at the time of vaccination, and no drug reactions/allergies, and a history of postpartum cardiomyopathy, and fibromyalgia who on 13-DEC-2006 was vaccinated with a dose of Pneumovax 23 (lot # 655588/0883F) IM in the right deltoid at 1 PM.  Concomitant therapy included SYNTHROID, TOPROL XL TABLETS, DIOVAN, montelukast sodium (MSD), ZYRTEC, and NASACORT.  On 13-DEC-2006, the patient reported that the shot "hurt".  On 14-DEC-2006, the patient developed a fever of 104 degrees and also had a welt on her arm which was vaccinated.  The patient sought medical attention.  The patient was seen on 18-DEC-2006 in the evening, and the welt had decreased as well as her fever, however the patient's arm was still sore and tender.  The patient was treated with ROCEPHIN.  At the time of reporting, the patient was recovering.  Additional information was received from the registered nurse.  On an unspecified date, the patient recovered.  No additional information is expected.
Sex: F
Vaccine: PPV
Symptoms: Erythema, Injection site reaction, Lymphadenopathy, Oedema peripheral
Clinical narrative: Information has been received from a physician concerning a female in her 50's who was vaccinated with Pneumovax 23.  Subsequently the patient experienced injection site reaction.  The patient's left upper arm became red and swollen.  The patient also experienced swollen lymph nodes.  Unspecified medical attention was sought.  Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Information has been received from a physician concerning a patient who was vaccinated with a dose of Pneumovax 23. Subsequently the patient developed pain, large swelling and redness at the injection site. The patient went to the emergency room and was treated with unspecified steroids. Subsequently, the patient recovered. The reporting physician considered pain, large swelling and redness at the injection site to be other important medical events. Additional information has been requested.
Age: 84.0
Sex: M
Vaccine: PPV
Symptoms: Injection site erythema, Injection site swelling, Pyrexia
Clinical narrative: Information has been received from a licensed practical nurse concerning an 84 year old male who in November 2000, was vaccinated with a first dose of Pneumovax 23.  On 18-DEC-2006, the patient was vaccinated with a second dose of Pneumovax 23 (lot #655291/0985F).  On 18-DEC-2006 the patient experienced fever and redness and swelling from shoulder to elbow.  The patient sought medical attention and was treated with cold compresses and TYLENOL.  On 20-DEC-2006, the patient recovered.  Additional information is not expected.
Age: 90.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Information has been received from a licensed practical nurse concerning a 80 year old female who on November 2001, was vaccinated with a first dose of Pneumovax 23. On 09-NOV-2006 the patient was vaccinated intramuscularly, into the left upper arm, with a second dose of Pneumovax 23. On 09-NOV-2006 the patient developed injection site redness and swelling. Unspecified medical attention was sought and no treatment was required. On 11-NOV-2006 the patient recovered from injection site redness and swelling. Additional information has been requested.
Age: 77.0
Sex: M
Vaccine: PPV
Symptoms: Injection site erythema, Injection site swelling, Local reaction
Clinical narrative: Information has been received from licensed practical nurse concerning a 77 year old male (weight 139#) with a history of stroke and blood pressure high who on 07-NOV-2006 was vaccinated with the first dose of Pneumovax 23 (lot #0985F/655291), 0.5 ml, IM.  Concomitant medication was not reported.  On 07-NOV-2006, the patient experienced local redness and swelling from her shoulder to elbow after vaccination with Pneumovax 23.  The patient was treated with cold compresses and TYLENOL.  On 09-NOV-2006 seventy-two hours after injection, the patient recovered from local redness and swelling from her shoulder to elbow.  The events were considered to be non-serious.  Additional information is not expected.
Age: 56.0
Sex: F
Vaccine: PPV
Symptoms: Injection site abscess, Injection site erythema, Injection site streaking
Clinical narrative: Information has been received from a pharmacist concerning a 56 year old female with a history of hypothyroidism and hypertension who in November 2006 (first week in November) was vaccinated with Pneumovax 23, SQ, 0.5 mL.  Concomitant therapy included amitriptyline hydrochloride (MSD), TENORMIN, PROMETRIUM and SYNTHROID.  In November 2006 three days after vaccination (second week in November), the patient experienced redness at injection site.  A few days later an abscess appeared at the injection site with red lines radiating down the arm.  The patient was seen by her physician and treated with LEVAQUIN and prednisone.  The patient told the pharmacist that she had received Pneumovax 23 each year for an unknown number of times.  Subsequently on an unspecified date, the patient recovered from redness at injection site and abscess appeared at injection site with red lines radiating down the arm.  Additional information has been requested.
Age: 79.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Information has been received from a physician concerning a 79 year old retired female patient who was vaccinated into the upper arm with a first dose of Pneumovax 23 (lot#651404/0352F).  Subsequently, the patient experienced a redness and swelling site reaction.  The patient was treated with BENADRYL.  Unspecified medical attention was sought.  Subsequently, the patient recovered.  No product quality complaint was involved.  Additional information is not expected.
Age: 44.0
Sex: F
Vaccine: FLUX, PPV, TTOX
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Information has been received from a certified medical assistant concerning a 44 year old female with no medical history and no known allergies who on 28-NOV-2006 was vaccinated with Pneumovax 23 (0.5 ml) (lot # 651437/0899F), in the left deltoid. Concomitant therapy that day included influenza virus vaccine, in the left deltoid, but different site, and a tetanus toxoid, in the right arm. On 30-NOV-2006 the patient experienced painful, swollen and red injection site from deltoid around to the armpit of the same arm. On 01-DEC-2006 the patient took over the counter antihistamines. The patient was instructed to take BENADRYL. The patient recovered. Additional information is not expected.
Age: 51.0
Sex: F
Vaccine: FLUX, PPV
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Pain in extremity
Clinical narrative: Information has been received from a certified medical assistant (CMA) concerning a 51 year old female with multiple sclerosis and no known allergies who on 02-DEC-2006 was vaccinated with first dose of Pneumovax 23 (lot # 651437/0899F) in left deltoid.  Also on 02-DEC-2006, the patient was vaccinated with flu vaccine in her right arm.  It was documented on the patient's chart on 07-DEC-2006, that on an unspecified date, the patient developed painful, swollen, and red injection site reaction from the deltoid around to the armpit of the same arm.  The patient sought medical attention.  No lab diagnostic studies were performed.  At the time of reporting, the patient had recovered.  Additional information was received from the physician's office.  It was reported that on 07-DEC-2007, the patient had called the office saying her left arm was very sore and slightly swollen at the injection site.  No other problems, the patient recovered.  No additional information is expected.
Sex: U
Vaccine: PPV
Symptoms: Body temperature, Injection site pain, Injection site swelling, Pyrexia
Clinical narrative: Information has been received from a healthcare worker (unspecified) concerning a patient (age and sex not reported) who on 22-DEC-2006 was vaccinated with Pneumovax 23 (lot # 655499/0988F). On 22-DEC-2006, the patient experienced swelling and pain at the injection site and fever. The outcome of the events was not reported. This is one of several reports from the same source. Additional information has been requested.
Sex: F
Vaccine: PPV
Symptoms: Dyspnoea, Musculoskeletal stiffness
Clinical narrative: Information has been received from a physician concerning a female (age not reported) who in approximately December 2006, was vaccinated with Pneumovax 23 (lot # not reported) 0.5 ml injection. In approximately December 2006, after the patient received the injection of Pneumovax 23 she developed shortness of breath and stiffness in upper area of the arm from the injection. The patient sought medical attention. The physician administered TYLENOL, steroids, and antibiotic to treat the problems. At the time of reporting, the patient was recovering. No other information was available at the time of reporting. Additional information has been requested.
Age: 65.0
Sex: M
Vaccine: PPV
Symptoms: Incorrect dose administered, Incorrect route of drug administration, Injection site erythema
Clinical narrative: Information has been received from a health professional concerning a 65 year old male with an allergy to sulfa drugs who on 27-DEC-2006 was vaccinated with a 0.1 ml dose of Pneumovax 23 (lot # 655288/1174F).  The Pneumovax 23 vaccine was administered intradermally into the right forearm by error.  Concomitant vaccination on 27-DEC-2006 included a first intradermal dose of PPD (manufacturer unknown) (lot # 33746).  The patient developed redness (2X2 inches) at the injection site but no pain or swelling was reported.  Ice was applied and the arm was checked on 29-DEC-2006 and the redness was gone and the patient recovered.  Additional information is not expected.
Age: 20.0
Sex: M
Vaccine: FLUX, PPV
Symptoms: Body temperature increased, Erythema, Oedema peripheral, Skin warm
Clinical narrative: Information has been received from a certified medical assistant concerning a 20 year old male with a history of respiratory tract infection who on 20-DEC-2006 was vaccinated SC with a 0.5 mL dose of Pneumovax 23 (Lot# 655291/0985F).  Concomitant vaccination on 20-DEC-2006 included a dose of influenza virus vaccine (unspecified) and AUGMENTIN.  On 21-DEC-2006 the patient experienced an 8 centimeter area that was red, warm and swollen and had a temperature of 101.  It was reported that the patient was recovering.  The patient sought unspecified medical attention.  Additional information has been requested.
Age: 51.0
Sex: F
Vaccine: PPV
Symptoms: Body temperature increased, Injection site erythema, Injection site pain, Injection site swelling, Pyrexia
Clinical narrative: Information has been received from a health professional concerning a 51 year old female with a history of respiratory tract infection who on 22-DEC-2006 was vaccinated SC with a 0.5 ml dose of Pneumovax 23 (lot # 655291/0985F).  Concomitant therapy included doxycycline.  On 22-DEC-2006 the patient developed redness, swelling and tenderness at injection site (softball size) and fever 101.  As of 27-DEC-2006 the patient was recovering and she sought unspecified medical attention.  Additional information has been requested.
Age: 41.0
Sex: F
Vaccine: FLUX, PPV
Symptoms: Chest discomfort, Injection site erythema, Injection site pain, Injection site swelling, Lacrimation increased
Clinical narrative: Information has been received from a registered nurse concerning a 41 year old female with allergies to diazepam and furosemide who on 25-OCT-2006 was vaccinated intramuscularly in the right deltoid with a dose of Pneumovax 23 (lot 651321/1036F). The patient was concomitantly vaccinated with influenza virus vaccine (unspecified) in the left deltoid. On 26-OCT-2006, the patient's arm was sore at site. The arm swelled in deltoid area, became red in deltoid area and under arm into the breast area. The area throbbed with pain for one week. The patient reported that it felt like a brick on her chest. Her eyes were watering and crusty for 3 days, and her nose ran. The patient was treated with diphenhydramine HCl. Subsequently, the patient recovered in one week. Additional information is not expected.
Age: 41.0
Sex: F
Vaccine: FLUX, PPV
Symptoms: Mucosal erosion, Pain, Rhinorrhoea
Clinical narrative: Information has been received from a registered nurse concerning a 41 year old female with allergies to diazepam and furosemide who on 25-OCT-2006 was vaccinated intramuscularly in the right deltoid with a dose of Pneumovax 23 (lot 651321/1036F). The patient was concomitantly vaccinated with influenza virus vaccine (unspecified) in the left deltoid. On 26-OCT-2006, the patient's arm was sore at site. The arm swelled in deltoid area, became red in deltoid area and under arm into the breast area. The area throbbed with pain for one week. The patient reported that it felt like a brick on her chest. Her eyes were watering and crusty for 3 days, and her nose ran. The patient was treated with diphenhydramine HCl. Subsequently, the patient recovered in one week. Additional information is not expected.
Age: 78.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site swelling, Local reaction
Clinical narrative: Information has been received from a licensed practical nurse concerning a 78 year old female with no relevant medical history or illness at the time of vaccination who on 05-DEC-2006 was vaccinated intramuscularly in the left deltoid with a 0.5 mL dose of Pneumovax 23 (lot 655152/0889F).  It was reported that on 24-OCT-2006, the patient was vaccinated in the left deltoid with a fifth dose of influenza vaccine (lot U2195AA).  Concomitant therapy included hydrochlorothiazide (manufacturer unknown), lisinopril (manufacturer unknown), and TOPROL.  On 05-DEC-2006, the patient presented with localized swelling and redness to the injection site.  The patient was advised to apply ice topically to site.  Subsequently, the patient recovered.  The nurse requested a lot check be performed on lot 655152/0889F.  The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory.  The lot complies with the standards of the agency and was released.  No additional information is expected.
Age: 67.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Information has been received from a licensed practical nurse concerning a 67 year old male with no relevant medical history or illness at the time of vaccination who on 05-DEC-2006 was vaccinated intramuscularly in the right deltoid with a 0.5 mL dose of Pneumovax 23 (lot 655152/0889F).  On 05-DEC-2006, the patient was concomitantly vaccinated intramuscularly in the left deltoid with a dose of FLUVAX (lot U2199AA).  On 06-DEC-2006, the patient developed redness and swelling at the injection site.  The patient presented in the office on 07-DEC-2006.  The patient's arm appeared swollen, and he was instructed to place ice on his arm.  Subsequently, the patient recovered.  The nurse requested a lot check be performed on lot 655152/0889F.  The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory.  The lot complies with the standards of the agency and was released.  No additional information is expected.